Bacterial species selective toxicity of two isomeric α/β- peptides: Role of membrane lipids

Molecular Membrane Biology

Volumn 22, Issue 6, 2005, Pages 457-469

  Epand, Raquel F ^a   Schmitt, Margaret A ^b   Gellman, Samuel H ^b   Sen, Arindam ^c   Auger, Michèle ^d   Hughes, Donald W ^e   Epand, Richard M ^a,e  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITÉ LAVAL   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Antimicrobial peptides; B. subtilis; Bacterial species; E. coli; Membrane lipids; Sponge phase

Indexed keywords

LIPOSOME; MEMBRANE LIPID; PEPTIDE DERIVATIVE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL MEMBRANE; BACTERIUM; CONTROLLED STUDY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; FREEZE FRACTURE; LIPID COMPOSITION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS SUBTILIS; CELL MEMBRANE; ESCHERICHIA COLI; MEMBRANE LIPIDS; PROTEIN STRUCTURE, SECONDARY; SPECIES SPECIFICITY;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PROKARYOTA;

EID: 29744438602     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.1080/09687860500370562     Document Type: Article

References (42)

1. Ames BN. 1966. Assay of inorganic phosphate, total phosphate and phosphatases. Meth Enzymol 8:115-118.
2. Angelova A, Ionov R, Koch MH, Rapp G. 2000. Interaction of the peptide antibiotic alamethicin with bilayer- and non-bilayer-forming lipids: Influence of increasing alamethicin concentration on the lipids supramolecular structures. Arch Biochem Biophys 378:93-106.
3. Arvidsson PI, Frackenpohl J, Ryder NS, Liechty B, Petersen F, Zimmermann H, Camenisch GP, Woessner R, Seebach D. 2001. On the antimicrobial and hemolytic activities of amphiphilic beta-peptides. Chembiochem 2:771-773.
4. Boman HG. 2003. Antibacterial peptides: Basic facts and emerging concepts. J Intern Med 254:197-215.
5. Burdett ID. 1979. Electron microscope study of the rod-to-coccus shape change in a temperature-sensitive rod- mutant of Bacillus subtilis. J Bacteriol 137:1395-1405.
6. Chapple DS, Hussain R, Joannou CL, Hancock RE, Odell E, Evans RW, Siligardi G. 2004. Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide. Antimicrob Agents Chemother 48:2190-2198.
7. Clejan S, Krulwich TA, Mondrus KR, Seto-Young D. 1986. Membrane lipid composition of obligately and facultatively alkalophilic strains of Bacillus spp. J Bacteriol 168:334-340.
8. Colotto A, Epand RM. 1997. Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of influenza virus to perturb bilayers. Biochemistry 36:7644-7651.
9. Colotto A, Lohner K, Laggner P. 1991. Small-angle X-ray-diffraction studies on the effects of melittin on lipid bilayer assemblies. J Appl Crystallography 24:847-851.
10. 2+-induced fusion and destabilization of liposomes. Biochemistry 24:3099-3106.
11. Epand RM, Vogel HJ. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462:11-28.
12. Fidai S, Farmer SW, Hancock RE. 1997. Interaction of cationic peptides with bacterial membranes. Meth Mol Biol 78:187-204.
13. Gustafsson J, Nylander T, Almgren M, Ljusberg-Wahren H. 1999. Phase behavior and aggregate structure in aqueous mixtures of sodium cholate and glycerol monooleate. J Colloid Interface Sci 211:326-335.
14. Hallock KJ, Lee DK, Omnaas J, Mosberg HI, Ramamoorthy A. 2002. Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys J 83:1004-1013.
15. Hamuro Y, Schneider JP, DeGrado WF. 1999. De novo design of antibacterial beta-peptides. J Am Chem Soc 121:12200-12201.
16. Keller SL, Gruner SM, Gawrisch K. 1996. Small concentrations of alamethicin induce a cubic phase in bulk phosphatidylethanolamine mixtures. Biochim Biophys Acta 1278:241-246.
17. Kol MA, van Laak AN, Rijkers DT, Killian JA, de Kroon AI, de Kruijff B. 2003. Phospholipid flop induced by transmembrane peptides in model membranes is modulated by lipid composition. Biochemistry 42:231-237.
18. Leuschner C, Hansel W 2004. Membrane disrupting lytic peptides for cancer treatments. Curr Pharm Des 10:2299-2310.
19. Liu D, DeGrado WF. 2001. De Novo design, synthesis and characterization of antimicrobial-peptides. J Am Chem Soc 123:7553-7559.
20. Liu DH, Choi S, Chen B, Doerksen RJ, Clements DJ, Winkler JD, Klein ML, DeGrado WR 2004. Nontoxic membrane-active antimicrobial arylamide oligomers. Angewandte Chemie - Int Ed 43:1158-1162.
21. Maldonado A, Urbach W, Ober R, Langevin D. 1996. Swelling behavior and local topology of an L(3) (sponge) phase. Phys Rev 54:1774-1778.
22. Mateu L, Luzzati V, London Y, Gould RM, Vosseberg FG. 1973. X-ray diffraction and electron microscope study of the interactions of myelin components. The structure of a lamellar phase with a 150 to 180 A repeat distance containing basic proteins and acidic lipids. J Mol Biol 75:697-709.
23. Matsuzaki K. 1998. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta 1376:391-400.
24. Moore RA, Bates NC, Hancock RE. 1986. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother 29:496-500.
25. Noordam PC, van Echteld CJ, de Kruijff B, Verkleij AJ, de Gier J. 1980. Barrier characteristics of membrane model systems containing unsaturated phosphatidylethanolamines. Chem Phys Lipids 27:221-232.
26. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. 1999. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: Relevance to the molecular basis for its non-cell-selective activity. Biochem J. 341(3):501-513.
27. Oren Z, Shai Y. 1997. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: Structure-function study. Biochemistry 36:1826-1835.
28. Papo N, Shai Y. 2003. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides 24:1693-1703.
29. Patch JA, Barron AE. 2003. Helical peptoid mimics of magainin-2 amide. J Am Chem Soc 125:12092-12093.
30. Porter EA, Wang X, Lee HS, Weisblum B, Gellman SH. 2000. Non-haemolytic beta-amino-acid oligomers. Nature 404:565.
31. Porter EA, Weisblum B, Gellman SH. 2002. Mimicry of host-defense peptides by unnatural oligomers: Antimicrobial beta-peptides. J Am Chem Soc 124:7324-7330.
32. Powers JP, Hancock RE. 2003. The relationship between peptide structure and antibacterial activity. Peptides 24:1681-1691.
33. Raguse TL, Porter EA, Weisblum B, Gellman SH. 2002. Structure-activity studies of 14-helical antimicrobial beta-peptides: Probing the relationship between conformational stability and antimicrobial potency. J Am Chem Soc 124:12774-12785.
34. Schmitt MA, Weisblum B, Gellman SH. 2004. Unexpected relationships between structure and function in alpha,beta-peptides: Antimicrobial foldamers with heterogeneous backbones. J Am Chem Soc 126:6848-6849.
35. Sen A, Hui SW, Mosgroberanthony M, Holm BA, Egan EA. 1988. Localization of lipid exchange sites between bulk lung surfactants and surface monolayer - freeze-fracture study. J Colloid Interface Sci 126:355-360.
36. Shai Y, Oren Z. 1996. Diastereoisomers of cytolysins, a novel class of potent antibacterial peptides. J Biol Chem 271:7305-7308.
37. Siegel DP, Epand RM. 2000. Effect of influenza hemagglutinin fusion peptide on lamellar/inverted phase transitions in dipalmitoleoylphosphatidylethanolamine: implications for membrane fusion mechanisms. Biochim Biophys Acta 1468:87-98.
38. Staudegger E, Prenner EJ, Kriechbaum M, Degovics G, Lewis RN, McElhaney RN, Lohner K. 2000. X-ray studies on the interaction of the antimicrobial peptide gramicidin S with microbial lipid extracts: Evidence for cubic phase formation. Biochim Biophys Acta 1468:213-230.
39. Steiner H, Hultmark D, Engstrom A, Bennich H, Boman HG. 1981. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292:246-248.
40. Tossi A, Sandri L, Giangaspero A. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
41. Wiese A, Gutsmann T, Seydel U. 2003. Towards antibacterial strategies: Studies on the mechanisms of interaction between antibacterial peptides and model membranes. J Endotoxin Res 9:67-84.
42. Zasloff M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84:5449-5453.